作者：
Adriana,Zingone [1]
;
Weixin,Wang [2]
;
Meghan,Corrigan-Cummins [2]
;
S Peter,Wu [1]
;
Ryan,Plyler [2]
;
Neha,Korde [1]
;
Mary,Kwok [1]
;
Elisabet E,Manasanch [1]
;
Nishant,Tageja [1]
;
Manisha,Bhutani [1]
;
Marcia,Mulquin [1]
;
Diamond,Zuchlinski [1]
;
Mary Ann,Yancey [1]
;
Mark,Roschewski [1]
;
Yong,Zhang [3]
;
Aldo M,Roccaro [3]
;
Irene M,Ghobrial [3]
;
Katherine R,Calvo [2]
;
Ola,Landgren [4]
作者单位：
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
[1]
Hematology Service, Department of Laboratory Medicine, Clinical Center, NIH, Bethesda, MD, USA.
[2]
Dana-Faber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA, USA.
[3]
Lymphoid Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA; Myeloma Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. Electronic address: landgrec@mskcc.org.
[4]
DOI
10.1016/j.cyto.2014.05.017
PMID
25043675
发布时间
2024-03-21
换一批
换一批
